We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Updated statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12 to 17 years
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on vaccination of children aged 12 to 15.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on a COVID-19 booster vaccine programme for winter 2021 to 2022.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
The JCVI is seeking evidence to inform possible changes to the HPV immunisation programme. We would like evidence around one-dose schedules for the HPV vaccine.
First published during the 2019 to 2022 Johnson Conservative government
The Joint Committee on Vaccination and Immunisation (JCVI) advises the UK government on vaccination and immunisation matters.
First published during the 2022 to 2024 Sunak Conservative government
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the effectiveness of the COVID-19 booster vaccination programme on the Omicron variant.
Statement from the Joint Committee on Vaccination and Immunisation on vaccinating children aged 5 to 11.
Final statement from the Joint Committee on Vaccines and Immunisation (JCVI) on the groups that should be prioritised for vaccination in phase 2 of the programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).